Kairos Pharma

Kairos Pharma is a clinical-stage biopharmaceutical company focused on developing a diverse range of cutting-edge therapies for cancer patients to reverse the suppression of the immune system by cancer. The company’s unique portfolio of seven drug candidates includes innovative peptide and small-molecule cancer immunotherapies that can reverse resistance to cancer treatments and immune resistance. Through its transformative technology, robust intellectual property (IP), and world-class team, the company has made unparalleled progress and is committed to making a significant impact on the most prevalent challenges in cancer treatment.